Our Unique Blazar® Platform: See What's New

Accelerating biosafety testing is essential for teams developing mAbs and recombinant proteins in rodent cell lines, especially CHO systems. Explore a next‑generation approach to rodent virus detection that replaces slow in vivo assays with a targeted NGS workflow designed for speed, sensitivity, and regulatory alignment. By combining extraction, degenerate PCR, and targeted sequencing into a streamlined platform, this method supports faster identification of potential viral contaminants, including low‑abundance or limited‑replicating genomes often missed by legacy assays. With GMP-compliant execution, dependable global testing sites, and an automated end-to-end pipeline, it’s built to reduce risk while supporting modern regulatory expectations.

See how this technology strengthens biosafety strategies and shortens timelines without compromising analytical rigor.